DDX21 at the Nexus of RNA Metabolism, Cancer Oncogenesis, and Host–Virus Crosstalk: Decoding Its Biomarker Potential and Therapeutic Implications
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252413581 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yalan Xiao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiological Medicine, School of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Carcinogenesis, DEAD-box RNA Helicases, Host-Pathogen Interactions. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, the Chongqing Science Fund for Distinguished Young Scholars, National Natural Science Foundation of China.
Abstract (Originalsprache)
DDX21, a member of the DEAD-box RNA helicase family, plays a pivotal role in various aspects of RNA metabolism, including ribosomal RNA (rRNA) processing, transcription, and translation. Its diverse functions in cancer progression and viral infections have attracted considerable attention. DDX21 exerts a pivotal function through ribosomal DNA (rDNA) transcription and rRNA processing. DDX21 is involved in different biological processes of mRNA transcription. It interacts with transcription factors, modulates RNA polymerase II elongation, binds R-loops to regulate transcription, and participates in alternative splicing. The elevated expression of DDX21 has been observed in most cancers, where it influences tumorigenesis by affecting ribosome biogenesis, transcription, genome stability, and cell cycle regulation. Additionally, DDX21 plays a key role in the antiviral defense of host by interacting with viral proteins to regulate essential stages of the infection process. This review provides a thorough examination of the biological functions of DDX21, its involvement in cancer progression and viral infections, and its potential as both a biomarker and a therapeutic target. Future studies should aim to clarify the specific mechanisms of the activity of DDX21, advance the development of targeted therapies, and assess its clinical relevance across various cancer types and stages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiological Medicine, School of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.
- Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing Medical University, Chongqing 400016, China.
ORCID-Profile: Yu Hou
Förderung
- the National Natural Science Foundation of China
- the Chongqing Science Fund for Distinguished Young Scholars
- National Natural Science Foundation of China
- Chongqing Science Fund for Distinguished Young Scholars
Zitieren
APA
Xiao, Y., Fan, J., Li, Z., & Hou, Y. (2024). DDX21 at the Nexus of RNA Metabolism, Cancer Oncogenesis, and Host–Virus Crosstalk: Decoding Its Biomarker Potential and Therapeutic Implications. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252413581
Vancouver
Xiao Y, Fan J, Li Z, Hou Y. DDX21 at the Nexus of RNA Metabolism, Cancer Oncogenesis, and Host–Virus Crosstalk: Decoding Its Biomarker Potential and Therapeutic Implications. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252413581
BibTeX
@article{Xiao2024,
author = {Xiao, Yalan and Fan, Jiankun and Li, Zhigang and Hou, Yu},
title = {DDX21 at the Nexus of RNA Metabolism, Cancer Oncogenesis, and Host–Virus Crosstalk: Decoding Its Biomarker Potential and Therapeutic Implications},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252413581}
}
EUVIMED